<html>
<head>PUBMED IDs for GDEP</head>
<body bgcolor='#C5F0F2'><h1>GDEP</h1><a href='https://pubmed.ncbi.nlm.nih.gov/7932622/'>Detection by polymerase chain reaction of genes encoding aminoglycoside-modifying enzymes in methicillin-resistant Staphylococcus aureus isolates of epidemic phage types. Belgian Study Group of Hospital Infections (GDEPIH/GOSPIZ).</a> October 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/8528099/'>Prodrugs in cancer chemotherapy.</a> September 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/8750009/'>The choice of prodrugs for gene directed enzyme prodrug therapy of cancer.</a> December 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/8750008/'>Gene therapy for the haemophilias.</a> January Gene therapy
  12<br><a href='https://pubmed.ncbi.nlm.nih.gov/11173653/'>Prodrugs in Cancer Chemotherapy.</a> January 1  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/11173653/'>Prodrugs in Cancer Chemotherapy.</a> January 1  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9406592/'>Intensely cytotoxic anthracycline prodrugs: glucuronides.</a> December 24  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9406588/'>Oncogenetic map of human genome.</a> December 24  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9625483/'>The design of selectively-activated anti-cancer prodrugs for use in antibody-directed and gene-directed enzyme-prodrug therapies.</a> June 13  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10465553/'>A 2-nitroimidazole carbamate prodrug of 5-amimo-1-(chloromethyl)-3-[(5,6,7-trimethoxyindol-2-yl)carbony l]-1,2-dihydro-3H--benz[E]indole (amino-seco-CBI-TMI) for use with ADEPT and GDEPT.</a> August 28  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10566154/'>The potential for gene therapy in pancreatic cancer.</a> November 24  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10617083/'>Nitrobenzyl carbamate prodrugs of enediynes for nitroreductase gene-directed enzyme prodrug therapy (GDEPT).</a> January 5  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10810644/'>Approaches to gene-directed enzyme prodrug therapy (GDEPT).</a> May 16  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10834273/'>Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT).</a> June 2  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10834272/'>Intensely cytotoxic anthracycline prodrugs: galactosides.</a> June 2  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10999476/'>Design and synthesis of novel pyrrolobenzodiazepine (PBD) prodrugs for ADEPT and GDEPT.</a> September 22  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11241346/'>Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives.</a> March 10  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11438835/'>Cell surface display of a lysosomal enzyme for extracellular gene-directed enzyme prodrug therapy.</a> July 5  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11498768/'>Direct retroviral delivery of human cytochrome P450 2B6 for gene-directed enzyme prodrug therapy of cancer.</a> August 11  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11536302/'>GDEP, a new gene differentially expressed in normal prostate and prostate cancer.</a> September 6  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11572666/'>Gene-directed enzyme prodrug therapy (GDEPT)--recognizing the present limitations of gene therapy for the treatment of cancer.</a> September 27  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11592840/'>High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue.</a> October 11  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11600229/'>Prodrug strategies in cancer therapy.</a> October 16  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11803140/'>Molecular approaches to chemo-radiotherapy.</a> January 23  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12040457/'>Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models.</a> June 1  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12040455/'>A novel mutation involving the carboxy terminal region of the FGFR3 gene in a multiple myeloma patient with t(4;14).</a> June 1  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12052216/'>Cytochrome P450 gene-directed enzyme prodrug therapy (GDEPT) for cancer.</a> June 8  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12052215/'>Beta-glucuronidase-mediated drug release.</a> June 8  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12052212/'>Nitroreductase-based GDEPT.</a> June 8  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12136937/'>Isophosphoramide mustard analogues as prodrugs for anticancer gene-directed enzyme-prodrug therapy (GDEPT).</a> July 26  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12244574/'>Mechanisms of cytotoxicity induced by horseradish peroxidase/indole-3-acetic acid gene therapy.</a> September 24  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12365005/'>Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy.</a> October 5  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12369976/'>Aerobic nitroreduction by flavoproteins: enzyme structure, mechanisms and role in cancer chemotherapy.</a> October 9  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12489027/'>Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.</a> December 19  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12517265/'>Cytochrome P450-based cancer gene therapy: current status.</a> January 9  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12553532/'>Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.</a> January 30  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12699387/'>Self-immolative nitrogen mustards prodrugs cleavable by carboxypeptidase G2 (CPG2) showing large cytotoxicity differentials in GDEPT.</a> April 18  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12773049/'>Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase.</a> May 30  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12939466/'>Gene-directed enzyme prodrug therapy for osteosarcoma: sensitization to CPT-11 in vitro and in vivo by adenoviral delivery of a gene encoding secreted carboxylesterase-2.</a> August 27  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/13678316/'>Phosphate prodrugs of isophosphoramide mustard.</a> September 19  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14529410/'>Prodrugs in genetic chemoradiotherapy.</a> October 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14555709/'>Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts.</a> October 14  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14623255/'>Bystander cell killing spreading from endothelial to tumor cells in a three-dimensional multicellular nodule model after Escherichia coli nitroreductase gene delivery.</a> November 19  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14657578/'>Clinical trials with GDEPT: cytosine deaminase and 5-fluorocytosine.</a> December 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14657576/'>In vitro and in vivo models for evaluation of GDEPT: quantifying bystander killing in cell cultures and tumors.</a> December 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14973055/'>Hypoxia targeted gene therapy to increase the efficacy of tirapazamine as an adjuvant to radiotherapy: reversing tumor radioresistance and effecting cure.</a> February 20  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/14997211/'>2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT.</a> March 5  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15115406/'>Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.</a> April 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15299187/'>Expression and initial promoter characterization of PCAN1 in retinal tissue and prostate cell lines.</a> August 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15343359/'>Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.</a> September 3  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15448734/'>CEA-negative glioblastoma and melanoma cells are sensitive to cytosine deaminase/5-fluorocytosine therapy directed by the carcinoembryonic antigen promoter.</a> September 28  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15448731/'>In vivo gene transfer using cetylated polyethylenimine.</a> September 28  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15565818/'>Tumor-activated prodrugs--a new approach to cancer therapy.</a> November 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15729367/'>Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdDelta24.</a> February 25  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15746571/'>From bench to bedside for gene-directed enzyme prodrug therapy of cancer.</a> March 5  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15805578/'>Introduction to the background, principles, and state of the art in suicide gene therapy.</a> April 5  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15911317/'>Nitroarylmethylcarbamate prodrugs of doxorubicin for use with nitroreductase gene-directed enzyme prodrug therapy.</a> May 25  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15958540/'>Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2.</a> June 17  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16010440/'>Anti-angiogenic strategies for cancer therapy (Review).</a> July 13  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16049130/'>Cancer chemotherapy and drug metabolism.</a> July 29  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16078849/'>Novel fluorinated prodrugs for activation by carboxypeptidase G2 showing good in vivo antitumor activity in gene-directed enzyme prodrug therapy.</a> August 5  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16129536/'>Aerobic 2- and 4-nitroreduction of CB 1954 by human liver.</a> September 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16163381/'>Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.</a> September 16  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16250833/'>Advances in prodrug design.</a> October 28  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16293390/'>Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.</a> November 19  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16391801/'>Delivery of the bacterial nitroreductase gene into endothelial cells prolongs the survival of tumour-bearing mice by bystander mechanisms.</a> January 5  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16393888/'>Metabolism and transport of oxazaphosphorines and the clinical implications.</a> January 6  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16410820/'>Tumor-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N.</a> January 18  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16625463/'>[Gene therapy approaches to gastrointestinal tumors].</a> April 21  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16859396/'>Novel gene-directed enzyme prodrug therapies against prostate cancer.</a> July 25  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16887103/'>Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.</a> August 5  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16977328/'>Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes.</a> September 16  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17036377/'>Gene therapy of liver cancer.</a> October 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17168697/'>Viral vectors for gene-directed enzyme prodrug therapy.</a> December 16  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17306358/'>Suicide genes for cancer therapy.</a> February 20  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17306356/'>Genes in the cure of cancer.</a> February 20  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17306351/'>Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.</a> February 20  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17326614/'>Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.</a> March 1  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17343804/'>Targeted, gene-directed enzyme prodrug therapies to tackle diversity and aggression of late stage prostate cancer.</a> March 9  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17401165/'>Production and release testing of ovine atadenovirus vectors.</a> April 3  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17468839/'>Molecular cloning and analysis of the human PCAN1 (GDEP) promoter.</a> May 1  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17510425/'>Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2.</a> May 19  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17522418/'>Recombinant adenovirus mediated prostate-specific enzyme pro-drug gene therapy regulated by prostate-specific membrane antigen (PSMA) enhancer/promoter.</a> May 25  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/23605630/'>Doxorubicin conjugates for selective delivery to tumors.</a> January 1  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/23605630/'>Doxorubicin conjugates for selective delivery to tumors.</a> January 1  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18212249/'>Improvement of cyclophosphamide activation by CYP2B6 mutants: from in silico to ex vivo.</a> January 24  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18288924/'>Gene directed enzyme prodrug therapy for ovarian cancer: could GDEPT become a promising treatment against ovarian cancer?</a> February 22  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18437183/'>Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2'-deoxyriboside via Salmonella against murine tumors.</a> April 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18437145/'>Association of a polymorphism in the lipin 1 gene with systolic blood pressure in men.</a> April 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18437121/'>Association between fatty acid binding protein 3 gene variants and essential hypertension in humans.</a> April 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18502571/'>Prodrug cancer gene therapy.</a> May 27  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18594769/'>Implication of functional activity for determining therapeutic efficacy of suicide genes in vitro.</a> July 3  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19259950/'>A novel technique to monitor carboxypeptidase G2 expression in suicide gene therapy using 19F magnetic resonance spectroscopy.</a> August 13  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19275523/'>Novel analogues of CC-1065 and the duocarmycins for the use in targeted tumour therapies.</a> May 21  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19275091/'>[Effect and mechanism of leptin on osteoblastic differentiation of hBMSCs].</a> June 13  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19274925/'>Relationship between the IL-12B promoter polymorphism and allergic rhinitis, familial asthma, serum total IgE, and eosinophil level in asthma patients.</a> May 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19353779/'>The piggyBac transposon is an integrating non-viral gene transfer vector that enhances the efficiency of GDEPT.</a> June 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19568409/'>Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies.</a> September 10  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19604626/'>Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.</a> February 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19649987/'>Recent progress in gene-directed enzyme prodrug therapy: an emerging cancer treatment.</a> November 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19852945/'>Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954.</a> February 24  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19924084/'>Bystander or no bystander for gene directed enzyme prodrug therapy.</a> February 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20560876/'>Targeted enzyme prodrug therapies.</a> February 16  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20586469/'>Silk-elastin-like hydrogel improves the safety of adenovirus-mediated gene-directed enzyme-prodrug therapy.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20891022/'>Noninvasive detection of carboxypeptidase G2 activity in vivo.</a> May 25  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21342105/'>Advances in imaging gene-directed enzyme prodrug therapy.</a> August 30  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21481534/'>Clinical potential of gene-directed enzyme prodrug therapy to improve radiation therapy in prostate cancer patients.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21726617/'>In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model.</a> June 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21753794/'>Noninvasive optical imaging of nitroreductase gene-directed enzyme prodrug therapy system in living animals.</a> July 21  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21824724/'>Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21824675/'>Speed-bumps ahead for the genetics of later-life diseases.</a> January 27  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22815775/'>Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancer.</a> March 22  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23399641/'>Creation and screening of a multi-family bacterial oxidoreductase library to discover novel nitroreductases that efficiently activate the bioreductive prodrugs CB1954 and PR-104A.</a> May 17  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23485727/'>Local bystander effect induces dormancy in human medullary thyroid carcinoma model in vivo.</a> July 31  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23563019/'>Prodrugs: a challenge for the drug development.</a> October 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23563004/'>RET codon 618 mutations in Saudi families with multiple endocrine neoplasia Type 2A and familial medullary thyroid carcinoma.</a> November 10  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23563003/'>No association between MGP rs1800802 polymorphism and stenosis of the coronary artery.</a> November 10  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23722591/'>A triple suicide gene strategy that improves therapeutic effects and incorporates multimodality molecular imaging for monitoring gene functions.</a> February 14  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23722564/'>Inhibitory effect of a standardized pomegranate fruit extract on Wnt signalling in 1, 2-dimethylhydrazine induced rat colon carcinogenesis.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23967078/'>Oncosuppressive suicide gene virotherapy &quot;PVH1-yCD/5-FC&quot; for pancreatic peritoneal carcinomatosis treatment: NFÎºB and Akt/PI3K involvement.</a> March 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24047137/'>Generation, validation, and application of a P450 homology model.</a> April 29  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24047118/'>Adaptation of impression cytology to enable conjunctival surface cell transcriptome analysis.</a> August 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24047116/'>MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab.</a> July 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24766134/'>A suicide gene therapy combining the improvement of cyclophosphamide tumor cytotoxicity and the development of an anti-tumor immune response.</a> May 12  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24977933/'>Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors.</a> May 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25338741/'>Gene-directed enzyme prodrug therapy.</a> July 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25529338/'>Targeted prodrug approaches for hormone refractory prostate cancer.</a> December 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26110789/'>Development of a Bioluminescent Nitroreductase Probe for Preclinical Imaging.</a> April 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26110787/'>Gamma-smooth muscle actin expression is associated with epithelial-mesenchymal transition and stem-like properties in hepatocellular carcinoma.</a> April 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26431849/'>Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility.</a> January 1  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26990592/'>Recombinant horseradish peroxidase variants for targeted cancer treatment.</a> January 19  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26990571/'>MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.</a> April 12  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26990556/'>Anguilla japonica lectin 1 delivery through adenovirus vector induces apoptotic cancer cell death through interaction with PRMT5.</a> March 19  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27424910/'>Theranostic Imaging of Cancer Gene Therapy.</a> July 19  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27573048/'>Current treatments for advanced melanoma and introduction of a promising novel gene therapy for melanoma (Review).</a> March 14  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28101690/'>Bacterial Toxins for Oncoleaking Suicidal Cancer Gene Therapy.</a> June 6  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28262557/'>Engineering a Multifunctional Nitroreductase for Improved Activation of Prodrugs and PET Probes for Cancer Gene Therapy.</a> March 7  2017<br></body></html>
